AMBA vs EXAS · rev $284.9M vs rev $2.76B
Ambarella Inc (AMBA) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Ambarella Inc (AMBA) is a semiconductor equipment & materials company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported AMBA revenue for 2025-01-31 was $284.9M. Net income was -$117.1M. Revenue was up 25.8% from 2024-01-31 to 2025-01-31. AMBA currently screens at market cap $2.86B.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
AMBA currently screens at market cap $2.86B. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the AMBA and EXAS stock pages for the full models.
Not investment advice.